Reduced bone mineral density and radial bone growth in young rabbits treated with dexamethasone eye drops

Hormone Research

Volumn 63, Issue 4, 2005, Pages 165-170

  Kugelberg, Maria ^a   Ohlsson, Claes ^b   Sävendahl, Lars ^c  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone mineral density; Dexamethasone; Glucocorticoids

Indexed keywords

DEXAMETHASONE; EYE DROPS; MEPREDNISONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE GROWTH; BONE MINERAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSE RESPONSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EYE SURGERY; FEMUR; LENS; NONHUMAN; PERIOSTEUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RABBIT; VOLUMETRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BONE DENSITY; BONE DEVELOPMENT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; RABBITS;

EID: 21044434056     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084684     Document Type: Article

References (23)

1. Dutton JJ, Baker JD, Hiles DA, Morgan KS: Viewpoints: Visual rehabilitation in aphakic children. Surv Ophthalmol 1990;34:365-384.
2. Lundvall A, Zetterstrom C: Complications after early surgery for congenital cataracts. Acta Ophthalmol Scand 1999;77:677-680.
3. Vasavada AR, Trivedi RH, Nath VC: Visual axis opacification after AcrySof intraocular lens implantation in children. J Cataract Refract Surg 2004;30:1073-1081.
4. Butenandt O: Rheumatoid arthritis and growth retardation in children: Treatment with human growth hormone. Eur J Pediatr 1979;130:15-28.
5. Guest G, Berard E, Crosnier H, Chevallier T, Rappaport R, Broyer M: Effects of growth hormone in short children after renal transplantation. French Society of Pediatric Nephrology. Pediatr Nephrol 1998;12:437-446.
6. Allen DB: Systemic effects of intranasal steroids: An endocrinologist's perspective. J Allergy Clin Immunol 2000;106:S179-S190.
7. Doull IJ, Freezer NJ, Holgate ST: Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151:1715-1719.
8. Verberne AA, Frost C, Roorda RJ, van der Laag H, Kerrebijn KF: One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med 1997;156:688-695.
9. Skoner DP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM, Seltzer JM, Storms WW, Wood RA: Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000;105:E23.
10. Szefler SJ: Pharmacokinetics of intranasal corticosteroids. J Allergy Clin Immunol 2001;108:26-31.
11. Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB: Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 2000;29:188-193.
12. Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC: Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology 2002;109:1887-1891.
13. Afandi B, Toumeh MS, Saadi HF: Cushing's syndrome caused by unsupervised use of ocular glucocorticoids. Endocr Pract 2003;9:526-529.
14. Kugelberg M, Shafiei K, Ohlsson C, Sävendahl L, Zetterström C: Glucocorticoid eye drops inhibit growth in the newborn rabbit. Acta Paediatr 2004; in press.
15. Gafni RI, McCarthy EF, Hatcher T, Meyers JL, Inoue N, Reddy C, Weise M, Barnes KM, Abad V, Baron J: Recovery from osteoporosis through skeletal growth: early bone mass acquisition has little effect on adult bone density. FASEB J 2002;16:736-738.
16. Lundvall A, Kugelberg TJ, Lundgren B, vd Mooren M, Zetterstrom C: Intraocular lens designed for the newborn infant eye. J Cataract Refract Surg 2001;27:928-933.
17. Windahl SH, Vidal O, Andersson G, Gustafsson JA, Ohlsson C: Increased cortical bone mineral content but unchanged trabecular bone mineral density in female ERbeta(-/-) mice. J Clin Invest 1999;104:895-901.
18. Vidal O, Lindberg MK, Hollberg K, Baylink DJ, Andersson G, Lubahn DB, Mohan S, Gustafsson JA, Ohlsson C: Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. Proc Natl Acad Sci USA 2000;97:5474-5479.
19. Baroncelli GI, Federico G, Bertelloni S, Sodini F, De Terlizzi F, Cadossi R, Saggese G: Assessment of bone quality by quantitative ultrasound of proximal phalanges of the hand and fracture rate in children and adolescents with bone and mineral disorders. Pediatr Res 2003; 54:125-136.
20. McIlwain HH: Glucocorticoid-induced osteoporosis: Pathogenesis, diagnosis, and management. Prev Med 2003;36:243-249.
21. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C: Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum 2003;48:3224-3229.
22. McGhee CN, Dean S, Danesh-Meyer H: Locally administered ocular corticosteroids: benefits and risks. Drug Saf 2002;25:33-55.
23. Kalsi GS, Gudauskas G, Bussanich N, Freeman DJ, Rootman J: Ocular pharmacokinetics of subconjunctivally administered cyclosporine in the rabbit. Can J Ophthalmol 1991;26: 200-205.